Lonza Group Ltd logo

Lonza Group Ltd

1
XSWX:LONN (Switzerland)   Ordinary Shares
CHF 526.40 (+3.87%) Apr 23
57.07
P/B:
3.87
Market Cap:
CHF 37.96B ($ 41.50B)
Enterprise V:
CHF 39.43B ($ 43.10B)
Volume:
229.57K
Avg Vol (2M):
213.69K
Also Trade In:
Volume:
229.57K
Avg Vol (2M):
213.69K
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for Lonza Group Ltd ( XSWX:LONN ) from 2002 to Apr 24 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Lonza Group stock (XSWX:LONN) PE ratio as of Apr 24 2024 is 57.07. More Details

Lonza Group Ltd (XSWX:LONN) PE Ratio (TTM) Chart

To

Lonza Group Ltd (XSWX:LONN) PE Ratio (TTM) Historical Data

Total 1254
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 14
Lonza Group PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-04-24 59.3 2024-02-21 51.1
2024-04-23 59.3 2024-02-20 51.2
2024-04-22 57.1 2024-02-19 51.4
2024-04-19 56.6 2024-02-16 51.5
2024-04-18 57.5 2024-02-15 51.6
2024-04-17 58.8 2024-02-14 52.1
2024-04-16 59.3 2024-02-13 49.8
2024-04-15 60.1 2024-02-12 50.3
2024-04-12 60.3 2024-02-09 50.0
2024-04-11 60.8 2024-02-08 50.1
2024-04-10 60.3 2024-02-07 49.2
2024-04-09 61.4 2024-02-06 50.4
2024-04-08 62.8 2024-02-05 50.0
2024-04-05 61.5 2024-02-02 48.5
2024-04-04 61.9 2024-02-01 48.2
2024-04-03 61.2 2024-01-31 47.8
2024-04-02 60.0 2024-01-30 48.7
2024-04-01 60.8 2024-01-29 48.9
2024-03-29 60.8 2024-01-26 47.7
2024-03-28 60.8 2024-01-25 41.7
2024-03-27 60.3 2024-01-24 43.0
2024-03-26 60.1 2024-01-23 42.1
2024-03-25 59.2 2024-01-22 42.0
2024-03-22 59.7 2024-01-19 40.7
2024-03-21 58.9 2024-01-18 41.0
2024-03-20 57.4 2024-01-17 40.4
2024-03-19 54.3 2024-01-16 41.6
2024-03-18 53.8 2024-01-15 41.7
2024-03-15 53.4 2024-01-12 41.5
2024-03-14 54.4 2024-01-11 41.6
2024-03-13 53.1 2024-01-10 41.0
2024-03-12 51.6 2024-01-09 40.1
2024-03-11 51.6 2024-01-08 39.3
2024-03-08 52.3 2024-01-05 38.7
2024-03-07 52.5 2024-01-04 39.5
2024-03-06 51.1 2024-01-03 39.4
2024-03-05 51.3 2024-01-02 39.8
2024-03-04 52.2 2024-01-01 39.8
2024-03-01 52.4 2023-12-29 39.8
2024-02-29 52.0 2023-12-28 39.6
2024-02-28 52.3 2023-12-27 23.0
2024-02-27 52.3 2023-12-26 23.2
2024-02-26 52.0 2023-12-25 23.2
2024-02-23 52.2 2023-12-22 23.2
2024-02-22 51.7 2023-12-21 22.7

Lonza Group Ltd (XSWX:LONN) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Description
Lonza Group ltd is a contract development and manufacturing organization, or CDMO. It operates under four segments: small molecules, biologics, cell & gene, and capsules & health ingredients. Lonza derives its revenue primarily from long-term supply agreements with pharmaceutical customers. The company provides a range of development and manufacturing services throughout the entire lifecycle of a product from drug research to commercial supply. The majority of Lonza's customers are pharmaceutical and biotechnology companies, academic institutions, and government research organizations.